ATRX and neoplasm: For tumors exhibiting MEN1, DAXX or ATRX alterations, there were no differences in age, gender, presence of a sporadic or functioning tumor, ENET stage, lesion size or location, disease progression or overall survival, when compared to the corresponding WT tumor population.